NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

臉部注射劑的全球市場:各產品,各應用領域,各地區的市場規模,佔有率及趨勢分析,各市場區隔預測(2021年∼2028年)

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application, By Region, And Segment Forecasts, 2021 - 2028

出版商 Grand View Research, Inc. 商品編碼 988092
出版日期 內容資訊 英文 172 Pages
商品交期: 2-10個工作天內
價格
臉部注射劑的全球市場:各產品,各應用領域,各地區的市場規模,佔有率及趨勢分析,各市場區隔預測(2021年∼2028年) Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application, By Region, And Segment Forecasts, 2021 - 2028
出版日期: 2021年01月29日內容資訊: 英文 172 Pages
簡介

全球臉部注射劑的市場規模在2021年∼2028年間,預測將以8.8%的年複合成長率擴大,到2028年達到277億美元。尤其是在新興市場,人們對外觀的興趣日益濃厚,這有望推動市場發展。另外,消費者偏愛微創手術的轉變有望支持市場的增長。根據美國整形外科學會(ASPS)的研究,肉毒桿菌毒素A和軟組織填充劑是2019年美國進行的前五項微創手術之一。因此,在未來幾年內,面部注射有望迅速增長。

本報告提供全球臉部注射劑市場相關調查分析,提供市場及產業預測,各市場區隔·各地區的預測,加上競爭情形相關的系統性資訊。

目錄

第1章 調查方法與範圍

第2章 摘要整理

第3章 臉部注射劑市場變數,趨勢及範圍

  • 滲透與成長預測的製圖
  • 市場動態
  • 非侵入性美容治療(醫美)的治療:市場分析工具

第4章 臉部注射劑市場:市場區隔分析,各產品,2016年∼2028年(百萬美元)

  • 定義和範圍
  • 各產品市場佔有率分析,2020年和2028年
  • 全球臉部注射劑市場,各產品,2016年∼2028年
  • 市場規模與預測及趨勢分析,2016年∼2028年
    • 膠原蛋白
    • 肉毒桿菌A型
    • 玻尿酸(HA)
    • 烴基磷灰石鈣(CaHA)
    • 聚合物填充物

第5章 臉部注射劑市場:市場區隔分析,各應用領域,2016年∼2028年(百萬美元)

  • 定義和範圍
  • 各應用領域市場佔有率分析,2020年和2028年
  • 全球臉部注射劑市場,各應用領域,2016年∼2028年
  • 市場規模與預測及趨勢分析,2016年∼2028年
    • 美容治療(醫美)
    • 治療

第6章 臉部注射劑市場:各地區市場分析,2016年∼2028年(百萬美元)

  • 定義和範圍
  • 各地區市場佔有率分析,2020年及2028年
  • 地區市場儀表板
  • 市場規模,預測,及趨勢分析,2020年∼2028年
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 瑞士
    • 荷蘭
    • 比利時
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 泰國
    • 韓國
    • 澳洲
    • 馬來西亞
    • 新加坡
    • 印尼
    • 菲律賓
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
  • 中東·非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其

第7章 臉部注射劑市場-競爭分析

  • 企業/競爭的分類(主要創新者,市場領導,新興企業)
  • 業者情勢
    • 主要的分銷商和流通管道合作夥伴清單
  • 主要企業的簡介
    • ALLERGAN
    • Ipsen
    • Merz Pharma
    • Suneva Medical, Inc.
    • Medytox Inc.
    • Sinclair Pharma
    • Bloomage BioTechnology Corporation Limited
    • Anika Therapeutics, Inc.
    • Prollenium Medical Technologies Inc.
    • Galderma S.A.
目錄
Product Code: GVR-1-68038-849-7

Facial Injectable Market Growth & Trends

The global facial injectable market size is expected to reach USD 27.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.8% from 2021 to 2028. The facial injectable is a substance that is used to reduce wrinkles and restore volume and fullness in the face. It is injected beneath the facial skin surface. Some commonly used facial injectables include hyaluronic acid, botulinum toxin type A, and polymer fillers.

The growing focus on physical appearance, especially in developing countries, is one of the key factors expected to drive the market. In addition, a shift in consumer preference toward minimally invasive procedures is expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries, such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market. Companies such as Allergan are also expanding their presence in the country owing to the rise in the middle-class population, backed by increasing disposable income.

With non-urgent and cosmetic surgeries being put on hold in most of the clinics across the world, surgeons are consulting their patients via telemedicine. Some surgeons are expecting an initial rush once the clinic reopens due to backlog cases, however, in the long run, they predict changes in the near future. There will also be an additional impact on revenue. With deep sanitization and PPEs to be worn for even injectable procedures, small businesses are expected to undergo the overhead expense and a decreased revenue, many could even shut down.

Facial Injectable Market Report Highlights

By product, the botulinum toxin type A segment led the market in 2020 and is projected to dominate throughout the forecast period. It is one of the most popularly used minimally invasive procedures

Based on application, the aesthetics segment is projected to be the fastest-growing segment over the forecast period owing to the rise in the use of facial injectables for aesthetic procedures, such as the treatment of wrinkles on the face

North America dominated the market in 2020 with a share of over 41.0% owing to the easy availability of the products and the presence of a large number of skilled surgeons

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Information procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third-party perspectives
    • 1.2.4. Primary research
  • 1.3. Information analysis
    • 1.3.1. Data analysis models
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing

Chapter 2. Executive Summary

Chapter 3. Facial Injectable Market Variables, Trends & Scope

  • 3.1. Penetration & Growth Prospect Mapping
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing beauty consciousness among consumers
      • 3.2.1.2. Shift in consumer preference toward minimally invasive procedures
    • 3.2.2. Market Restraint Analysis
  • 3.3. Non-invasive Aesthetic Treatment: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat from new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Social Landscape
      • 3.3.2.3. Technology Landscape
      • 3.3.2.4. Legal Landscape

Chapter 4. Facial Injectable Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Product market share analysis, 2020 & 2028
  • 4.3. Global Facial Injectable Market, By Product, 2016 - 2028
  • 4.4. Market Size & Forecasts and Trend Analysis, 2016 - 2028 for the following
    • 4.4.1. Collagen
    • 4.4.2. Botulinum Toxin Type A
    • 4.4.3. Hyaluronic Acid (HA)
    • 4.4.4. Calcium Hydroxylapatite (CaHA)
    • 4.4.5. Polymer Fillers
      • 4.4.5.1. Polymethylmethacrylate beads (PMMA Microspheres)
      • 4.4.5.2. Poly-L-Lactic Acid (PLLA)

Chapter 5. Facial Injectable Market: Segment Analysis, By Application, 2016 - 2028 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Application market share analysis, 2020 & 2028
  • 5.3. Global Facial Injectable Market, By Application, 2016 - 2028
  • 5.4. Market Size & Forecasts and Trend Analysis, 2016 - 2028 for the following
    • 5.4.1. Aesthetics
    • 5.4.2. Therapeutics

Chapter 6. Facial Injectable Market: Regional Market Analysis, By Region, 2016 - 2028 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Regional market share analysis, 2020 & 2028
  • 6.3. Regional Market Dashboard
  • 6.4. Market Size, & Forecasts, and Trend Analysis, 2020 to 2028:
  • 6.5. North America
    • 6.5.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.5.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
    • 6.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.5.4. U.S.
      • 6.5.4.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.5.4.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.5.5. Canada
      • 6.5.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.5.5.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
  • 6.6. Europe
    • 6.6.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.6.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
    • 6.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.4. Germany
      • 6.6.4.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.4.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.5. U.K.
      • 6.6.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.5.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.6. France
      • 6.6.6.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.6.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.7. Italy
      • 6.6.7.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.7.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.8. Spain
      • 6.6.8.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.8.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.9. Switzerland
      • 6.6.9.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.9.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.10. Netherlands
      • 6.6.10.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.10.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.6.11. Belgium
      • 6.6.11.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.6.11.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.7.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
    • 6.7.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.4. China
      • 6.7.4.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.5. Japan
      • 6.7.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.6. India
      • 6.7.6.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.6.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.7. Thailand
      • 6.7.7.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.7.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.8. South Korea
      • 6.7.8.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.8.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.9. Australia
      • 6.7.9.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.9.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.10. Malaysia
      • 6.7.10.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.10.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.11. Singapore
      • 6.7.11.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.11.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.12. Indonesia
      • 6.7.12.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.12.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.7.13. Philippines
      • 6.7.13.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.7.13.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.8.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
    • 6.8.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.4. Brazil
      • 6.8.4.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.4.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.5. Mexico
      • 6.8.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.5.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.6. Argentina
      • 6.8.6.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.6.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.7. Colombia
      • 6.8.7.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.7.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.8.8. Chile
      • 6.8.8.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.8.8.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
  • 6.9. Middle East and Africa
    • 6.9.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
    • 6.9.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.2.1. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.3. South Africa
      • 6.9.3.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.3.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.4. Saudi Arabia
      • 6.9.4.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.4.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.5. UAE
      • 6.9.5.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.5.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.6. Israel
      • 6.9.6.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.6.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
    • 6.9.7. Turkey
      • 6.9.7.1. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
      • 6.9.7.2. Market estimates and forecast, by application, 2016 - 2028 (USD Million)

Chapter 7. Facial Injectable Market - Competitive Analysis

  • 7.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 7.2. Vendor Landscape
    • 7.2.1. List of key distributors and channel partners
  • 7.3. Key companies profiled
    • 7.3.1. ALLERGAN
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Ipsen
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Merz Pharma
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Suneva Medical, Inc.
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Medytox Inc.
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Sinclair Pharma
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Bloomage BioTechnology Corporation Limited
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Anika Therapeutics, Inc.
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Prollenium Medical Technologies Inc.
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Galderma S.A.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives.

List of Tables

  • Table 1 Global facial injectable market, by region, 2016 - 2028 (USD Million)
  • Table 2 Global facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 3 Global facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 4 North America facial injectable market, by country, 2016 - 2028 (USD Million)
  • Table 5 North America facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 6 North America facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 7 U.S. facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 8 U.S. facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 9 Canada facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 10 Canada facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 11 Europe facial injectable market, by country, 2016 - 2028 (USD Million)
  • Table 12 Europe facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 13 Europe facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 14 U.K. facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 15 U.K. facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 16 Germany facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 17 Germany facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 18 France facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 19 France facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 20 Italy facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 21 Italy facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 22 Spain facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 23 Spain facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 24 Switzerland facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 25 Switzerland facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 26 Netherlands facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 27 Netherlands facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 28 Belgium facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 29 Belgium facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 30 Asia Pacific facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 31 Asia Pacific facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 32 Japan Facial Injectable Market, by product, 2016 - 2028 (USD Million)
  • Table 33 Japan Facial Injectable Market, by application, 2016 - 2028 (USD Million)
  • Table 34 China facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 35 China facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 36 India facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 37 India facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 38 Thailand facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 39 Thailand facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 40 South Korea facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 41 South Korea facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 42 Australia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 43 Australia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 44 Malaysia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 45 Malaysia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 46 Singapore facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 47 Singapore facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 48 Indonesia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 49 Indonesia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 50 Philippines facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 51 Philippines facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 52 Latin America facial injectable market, by country, 2016 - 2028 (USD Million)
  • Table 53 Latin America facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 54 Latin America facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 55 Brazil facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 56 Brazil facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 57 Mexico facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 58 Mexico facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 59 Argentina facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 60 Argentina facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 61 Colombia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 62 Colombia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 63 Chile facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 64 Chile facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 65 Middle East & Africa facial injectable market, by country, 2016 - 2028 (USD Million)
  • Table 66 Middle East & Africa facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 67 Middle East & Africa facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 68 South Africa facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 69 South Africa facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 70 Saudi Arabia facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 71 Saudi Arabia facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 72 UAE facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 73 UAE facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 74 Israel facial injectable market, by product, 2016 - 2028 (USD Million)
  • Table 75 Israel facial injectable market, by application, 2016 - 2028 (USD Million)
  • Table 76 Turkey Facial Injectable Market, by product, 2016 - 2028 (USD Million)
  • Table 77 Turkey Facial Injectable Market, by application, 2016 - 2028 (USD Million)

List of Figures

  • Figure 1 Market research process
  • Figure 2 Information procurement
  • Figure 3 Primary research pattern
  • Figure 4 Market research approaches
  • Figure 5 Value chain-based sizing & forecasting
  • Figure 6 QFD modelling for market share assessment
  • Figure 7 Market formulation & validation
  • Figure 8 Facial injectable market segmentation
  • Figure 9 Market driver relevance analysis (Current & future impact)
  • Figure 10 Market restraint relevance analysis (Current & future impact)
  • Figure 11 Market challenge relevance analysis (Current & future impact)
  • Figure 12 Penetration & growth prospect mapping
  • Figure 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Figure 14 Porter's five forces analysis
  • Figure 15 Market penetration vs growth prospect mapping
  • Figure 16 Facial injectable market: product movement analysis
  • Figure 17 Regional marketplace: Key takeaways
  • Figure 18 Regional outlook, 2020 & 2028
  • Figure 19 North America facial injectable market, 2016 - 2028 (USD Million)
  • Figure 20 U.S. facial injectable market, 2016 - 2028 (USD Million)
  • Figure 21 Canada facial injectable market, 2016 - 2028 (USD Million))
  • Figure 22 Europe facial injectable market, 2016 - 2028 (USD Million)
  • Figure 23 U.K. facial injectable market, 2016 - 2028 (USD Million)
  • Figure 24 Germany facial injectable market, 2016 - 2028 (USD Million)
  • Figure 25 Italy facial injectable market, 2016 - 2028 (USD Million)
  • Figure 26 Spain facial injectable market, 2016 - 2028 (USD Million)
  • Figure 27 France facial injectable market, 2016 - 2028 (USD Million)
  • Figure 28 Switzerland facial injectable market, 2016 - 2028 (USD Million)
  • Figure 29 Netherlands facial injectable market, 2016 - 2028 (USD Million)
  • Figure 30 Belgium facial injectable market, 2016 - 2028 (USD Million)
  • Figure 31 Asia Pacific facial injectable market, 2016 - 2028 (USD Million)
  • Figure 32 Japan facial injectable market, 2016 - 2028 (USD Million)
  • Figure 33 China facial injectable market, 2016 - 2028 (USD Million)
  • Figure 34 India facial injectable market, 2016 - 2028 (USD Million)
  • Figure 35 Thailand facial injectable market, 2016 - 2028 (USD Million)
  • Figure 36 South Korea facial injectable market, 2016 - 2028 (USD Million)
  • Figure 37 Australia facial injectable market, 2016 - 2028 (USD Million)
  • Figure 38 Malaysia facial injectable market, 2016 - 2028 (USD Million)
  • Figure 39 Singapore facial injectable market, 2016 - 2028 (USD Million)
  • Figure 40 Indonesia facial injectable market, 2016 - 2028 (USD Million)
  • Figure 41 Philippines facial injectable market, 2016 - 2028 (USD Million)
  • Figure 42 Latin America facial injectable market, 2016 - 2028 (USD Million)
  • Figure 43 Brazil facial injectable market, 2016 - 2028 (USD Million)
  • Figure 44 Mexico facial injectable market, 2016 - 2028 (USD Million)
  • Figure 45 Argentina facial injectable market, 2016 - 2028 (USD Million)
  • Figure 46 Colombia facial al injectable market, 2016 - 2028 (USD Million)
  • Figure 47 Chile facial al injectable market, 2016 - 2028 (USD Million)
  • Figure 48 MEA facial injectable market, 2016 - 2028 (USD Million)
  • Figure 49 South Africa facial injectable market, 2016 - 2028 (USD Million)
  • Figure 50 Saudi Arabia facial injectable market, 2016 - 2028 (USD Million)
  • Figure 51 UAE facial injectable market, 2016 - 2028 (USD Million)
  • Figure 52 Israel facial injectable market, 2016 - 2028 (USD Million)
  • Figure 53 Turkey facial injectable market, 2016 - 2028 (USD Million)